Notice the unusual mentions here today of Baupost and Abrams, either indirectly thru Orex or directly such as post from poster gerald..
“But, in the end it is up to Baupost/Abrams how long they put up with poor sales of a good drug”
Kinda gives it away, imo - stupid is as stupid does.
Btw, if hypothetical scenario put forth in last few days has validity, Abrams acquiring additional 4 million shares in open market during 4Q2017, potentially, is a sign Baupost/Abrams want to put up a fight.
ALL IMO